LIN28A and esophageal squamous cell carcinoma: In conclusion, our findings demonstrate that LncRNA MALAT1 plays a crucial role in the progression of ESCC by regulating the expression of β-catenin and Lin28 via Ezh2, indicating inhibition of MALAT1 might be a potential target for treatment of ESCC.